Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016 (2016), Article ID 1580701, 16 pages
http://dx.doi.org/10.1155/2016/1580701
Research Article

Lovastatin Decreases the Expression of CD133 and Influences the Differentiation Potential of Human Embryonic Stem Cells

Institute of Molecular and Cell Biology, University of Tartu, Riia 23, 51010 Tartu, Estonia

Received 8 March 2016; Accepted 18 April 2016

Academic Editor: Mario Cioce

Copyright © 2016 Ade Kallas-Kivi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. R. Cardwell, B. M. Hicks, C. Hughes, and L. J. Murray, “Statin use after diagnosis of breast cancer and survival: a population-based cohort study,” Epidemiology, vol. 26, no. 1, pp. 68–78, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Lötsch, O. Königsbrügge, F. Posch, C. Zielinski, I. Pabinger, and C. Ay, “Statins are associated with low risk of venous thromboembolism in patients with cancer: a prospective and observational cohort study,” Thrombosis Research, vol. 134, no. 5, pp. 1008–1013, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Karlic, R. Thaler, C. Gerner et al., “Inhibition of the mevalonate pathway affects epigenetic regulation in cancer cells,” Cancer Genetics, vol. 208, no. 5, pp. 241–252, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. P. W. Andrews, “Human embryonal carcinoma cells in culture do not synthesize fibronectin until they differentiate,” International Journal of Cancer, vol. 30, no. 5, pp. 567–571, 1982. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Mavilio, A. Simeone, E. Boncinelli, and P. W. Andrews, “Activation of four homeobox gene clusters in human embryonal carcinoma cells induced to differentiate by retinoic acid,” Differentiation, vol. 37, no. 1, pp. 73–79, 1988. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Duran, P. J. Talley, J. Walsh, C. Pigott, I. E. Morton, and P. W. Andrews, “Hybrids of pluripotent and nullipotent human embryonal carcinoma cells: partial retention of a pluripotent phenotype,” International Journal of Cancer, vol. 93, no. 3, pp. 324–332, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Gauthaman, M. Richards, J. Wong, and A. Bongso, “Comparative evaluation of the effects of statins on human stem and cancer cells in vitro,” Reproductive BioMedicine Online, vol. 15, no. 5, pp. 566–581, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Gauthaman, N. Manasi, and A. Bongso, “Statins inhibit the growth of variant human embryonic stem cells and cancer cells in vitr,” British Journal of Pharmacology, vol. 157, no. 6, pp. 962–973, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. F. W. King, C. Ritner, W. Liszewski et al., “Subpopulations of human embryonic stem cells with distinct tissue-specific fates can be selected from pluripotent cultures,” Stem Cells and Development, vol. 18, no. 10, pp. 1441–1450, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Kemper, M. R. Sprick, M. de Bree et al., “The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation,” Cancer Research, vol. 70, no. 2, pp. 719–729, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Corbeil, A.-M. Marzesco, M. Wilsch-Bräuninger, and W. B. Huttner, “The intriguing links between prominin-1 (CD133), cholesterol-based membrane microdomains, remodeling of apical plasma membrane protrusions, extracellular membrane particles, and (neuro)epithelial cell differentiation,” FEBS Letters, vol. 584, no. 9, pp. 1659–1664, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Corbeil, K. Roper, M. J. Hannah, A. Hellwig, and W. B. Huttner, “Selective localization of the polytopic membrane protein prominin in microvilli of epithelial cells—a combination of apical sorting and retention in plasma membrane protrusions,” Journal of Cell Science, vol. 112, part 7, pp. 1023–1033, 1999. View at Google Scholar
  13. S. R. Pine, B. M. Ryan, L. Varticovski, A. I. Robles, and C. C. Harris, “Microenvironmental modulation of asymmetric cell division in human lung cancer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 5, pp. 2195–2200, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. J. A. Knoblich, “Asymmetric cell division during animal development,” Nature Reviews Molecular Cell Biology, vol. 2, no. 1, pp. 11–20, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. A. H. Yin, S. Miraglia, E. D. Zanjani et al., “AC133, a novel marker for human hematopoietic stem and progenitor cells,” Blood, vol. 90, no. 12, pp. 5002–5012, 1997. View at Google Scholar · View at Scopus
  16. C. A. Fargeas, D. Corbeil, and W. B. Huttner, “AC133 antigen, CD133, prominin-1, prominin-2, etc.: prominin family gene products in need of a rational nomenclature,” Stem Cells, vol. 21, no. 4, pp. 506–508, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. C. A. Fargeas, M. Florek, W. B. Huttner, and D. Corbeil, “Characterization of prominin-2, a new member of the prominin family of pentaspan membrane glycoproteins,” The Journal of Biological Chemistry, vol. 278, no. 10, pp. 8586–8596, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. C. A. Fargeas, A. Joester, E. Missol-Kolka, A. Hellwig, W. B. Huttner, and D. Corbeil, “Identification of novel prominin-1/CD133 splice variants with alternative C-termini and their expression in epididymis and testis,” Journal of Cell Science, vol. 117, part 18, pp. 4301–4311, 2004. View at Google Scholar
  19. M. Akita, K. Tanaka, N. Murai et al., “Detection of CD133 (prominin-1) in a human hepatoblastoma cell line (HuH-6 clone 5),” Microscopy Research and Technique, vol. 76, no. 8, pp. 844–852, 2013. View at Publisher · View at Google Scholar
  20. M. Jakóbisiak, S. Bruno, J. S. Skierski, and Z. Darzynkiewicz, “Cell cycle-specific effects of lovastatin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 9, pp. 3628–3632, 1991. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Kallas, M. Pook, A. Trei, and T. Maimets, “SOX2 is regulated differently from NANOG and OCT4 in human embryonic stem cells during early differentiation initiated with sodium butyrate,” Stem Cells International, vol. 2014, Article ID 298163, 12 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. K. A. D'Amour, A. G. Bang, S. Eliazer et al., “Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells,” Nature Biotechnology, vol. 24, no. 11, pp. 1392–1401, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. D. J. Rodda, J.-L. Chew, L.-H. Lim et al., “Transcriptional regulation of nanog by OCT4 and SOX2,” The Journal of Biological Chemistry, vol. 280, no. 26, pp. 24731–24737, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. J. P. Saxe, A. Tomilin, H. R. Schöler, K. Plath, and J. Huang, “Post-translational regulation of Oct4 transcriptional activity,” PLoS ONE, vol. 4, no. 2, Article ID e4467, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. M. J. Stewart, M. Bossé, K. Chadwick, P. Menendez, S. C. Bendall, and M. Bhatia, “Clonal isolation of hESCs reveals heterogeneity within the pluripotent stem cell compartment,” Nature Methods, vol. 3, no. 10, pp. 807–815, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Toyooka, D. Shimosato, K. Murakami, K. Takahashi, and H. Niwa, “Identification and characterization of subpopulations in undifferentiated ES cell culture,” Development, vol. 135, no. 5, pp. 909–918, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. R. A. Neumüller and J. A. Knoblich, “Dividing cellular asymmetry: asymmetric cell division and its implications for stem cells and cancer,” Genes and Development, vol. 23, no. 23, pp. 2675–2699, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. K. A. Lewis, S. A. Holstein, and R. J. Hohl, “Lovastatin alters the isoprenoid biosynthetic pathway in acute myelogenous leukemia cells in vivo,” Leukemia Research, vol. 29, no. 5, pp. 527–533, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Frick, J. Dulak, J. Cisowski et al., “Statins differentially regulate vascular endothelial growth factor synthesis in endothelial and vascular smooth muscle cells,” Atherosclerosis, vol. 170, no. 2, pp. 229–236, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. Á. Apáti, T. I. Orbán, N. Varga et al., “High level functional expression of the ABCG2 multidrug transporter in undifferentiated human embryonic stem cells,” Biochimica et Biophysica Acta (BBA)—Biomembranes, vol. 1778, no. 12, pp. 2700–2709, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Itskovitz-Eldor, M. Schuldiner, D. Karsenti et al., “Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers,” Molecular Medicine, vol. 6, no. 2, pp. 88–95, 2000. View at Google Scholar · View at Scopus
  32. A. B. Mak, A. M. L. Nixon, S. Kittanakom et al., “Regulation of CD133 by HDAC6 promotes β-catenin signaling to suppress cancer cell differentiation,” Cell Reports, vol. 2, no. 4, pp. 951–963, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. P. A. McCue, M. L. Gubler, M. I. Sherman, and B. N. Cohen, “Sodium butyrate induces histone hyperacetylation and differentiation of murine embryonal carcinoma cells,” Journal of Cell Biology, vol. 98, no. 2, pp. 602–608, 1984. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Campos and C. C. Herold-Mende, “Both CD133+ and CD133- cances stem cells have different expression profiles in transcriptional activities and extracellular matrix molecules,” International Journal of Cancer, vol. 128, pp. 501–510, 2011. View at Google Scholar
  35. C. Lottaz, D. Beier, K. Meyer et al., “Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin,” Cancer Research, vol. 70, no. 5, pp. 2030–2040, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Michalczyk and M. Ziman, “Nestin structure and predicted function in cellular cytoskeletal organisation,” Histology and Histopathology, vol. 20, no. 2, pp. 665–671, 2005. View at Google Scholar · View at Scopus
  37. G. J. Inman, F. J. Nicolás, J. F. Callahan et al., “SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7,” Molecular Pharmacology, vol. 62, no. 1, pp. 65–74, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Vogt, R. Traynor, and G. P. Sapkota, “The specificities of small molecule inhibitors of the TGFß and BMP pathways,” Cellular Signalling, vol. 23, no. 11, pp. 1831–1842, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. C.-L. Chen, S. H. Shuan, and S. H. Jung, “Cholesterol modulates cellular TGF-β responsiveness by altering TGF-β binding to TGF-β receptors,” Journal of Cellular Physiology, vol. 215, no. 1, pp. 223–233, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. H. You, W. Ding, and C. B. Rountree, “Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-β,” Hepatology, vol. 51, no. 5, pp. 1635–1644, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. X. Yu, Y. Lin, X. Yan, Q. Tian, L. Li, and E. H. Lin, “CD133, stem cells, and cancer stem cells: myth or reality?” Current Colorectal Cancer Reports, vol. 7, no. 4, pp. 253–259, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Ambady, C. Malcuit, O. Kashpur et al., “Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells,” International Journal of Developmental Biology, vol. 54, no. 11-12, pp. 1743–1754, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. M. A. Rijlaarsdam, H. A. D. M. van Herk, A. J. M. Gillis et al., “Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours,” British Journal of Cancer, vol. 105, no. 6, pp. 854–863, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Kallas, M. Pook, A. Trei, and T. Maimets, “Assessment of the potential of CDK2 inhibitor NU6140 to influence the expression of pluripotency markers NANOG, OCT4, and SOX2 in 2102Ep and H9 cells,” International Journal of Cell Biology, vol. 2014, Article ID 280638, 16 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus